10x Genomics Inc

TXG USD0.00001
Create an alert
Sell$76.52
Buy$76.59
$0.45 (0.58%)
Last updated today at
Back to dashboard

Company Information

About this company

10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.

Key people

John R. Stuelpnagel
Independent Chairman of the Board
Benjamin J. Hindson
President, Co-Founder, Chief Scientific Officer, Director
Serge Wilson Saxonov
Chief Executive Officer, Co-Founder, Director
Adam S. Taich
Chief Financial Officer
Sridhar Kosaraju
Independent Director
Alan V. Mateo
Independent Director
Kimberly J. Popovits
Independent Director
Shehnaaz Suliman
Independent Director
Click to see more

Key facts

  • Shares in issue
    120.21m
  • EPIC
    TXG
  • ISIN
    US88025U1097
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $10.03bn
  • Employees
    1,178
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.